LYMPHOGENiX

Covent Garden, United Kingdom

LYMPHOGENiX aim to be a global leader in lymphatic science, addressing unmet needs in both human and animal health.

$340K raised

Jul 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has LYMPHOGENiX raised?

LYMPHOGENiX has raised $340K in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2025.

Who are LYMPHOGENiX's investors?

LYMPHOGENiX's investors include Keio Innovation Initiative, Glocalink, S-Quatre Corporation, AndJ Holdings.

Where is LYMPHOGENiX headquartered?

LYMPHOGENiX is headquartered in Covent Garden, United Kingdom.

What does LYMPHOGENiX do?

LYMPHOGENiX aim to be a global leader in lymphatic science, addressing unmet needs in both human and animal health.

What stage is LYMPHOGENiX at?

LYMPHOGENiX is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 8, 2025.

MLA

"LYMPHOGENiX — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/lymphogenix. Accessed July 2, 2026.

APA

VCBacked. (2025). LYMPHOGENiX — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lymphogenix

Wikipedia (cite web)

{{cite web |title=LYMPHOGENiX — Funding & Investors |url=https://www.vcbacked.co/company/lymphogenix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 8, 2025.